embecta
At embecta (formerly part of BD) we are a global medical technology company singularly focused on improving the lives of people living with diabetes. For nearly 100 years, we’ve been developing and providing solutions to the diabetes community. We are the leaders in insulin delivery, with more than 30 million people in over 100 countries relying on our pen needle and syringe products.
See below for the Latest embecta News, Analysis, Profit Results, Share Price Information, and Commentary.
Healthcare Asia Medtech Awards 2023 Winner: embecta
embecta took home the Digital Innovation of the Year - Japan at the Healthcare Asia Medtech Awards 2023.
Healthcare Asia Medtech Awards 2023 Winner: embecta
embecta took home the Digital Innovation of the Year - Japan at the Healthcare Asia Medtech Awards 2023.
embecta Japan wins award for mobile app that supports diabetes patients between doctor visits
A free educational and lifestyle tool designed to help people with diabetes.
Most Read
1. IHH invests in Belun Technology for AI-powered sleep diagnostic technology 2. Tan Tock Seng Hospital introduces flexible working shifts for nurses 3. Metro Pacific Health Corporation acquires UHBI-PDH in Parañaque City 4. HKUST and Beijing Tiantan Hospital to launch training programme for physicians 5. Swire Pacific acquires controlling stake in DeltaHealthResource Center
Event News
Event News
Gleneagles Hospital CEO plants his hospitality roots into healthcare
Healthcare
CEO Thomas Wee shares his strategy and vision for a patient-centric Singapore hospital at 2024 Healthcare Asia Summit.
Healthcare
Gleneagles Hospital CEO plants his hospitality roots into healthcare
CEO Thomas Wee shares his strategy and vision for a patient-centric Singapore hospital at 2024 Healthcare Asia Summit.
Videos
Partner Sites
Join the community
Commentary
Evolving the Healthcare landscape in Singapore with Integrated Ambulatory Surgical Centres